Unknown

Dataset Information

0

Interplay between protein glycosylation pathways in Alzheimer's disease.


ABSTRACT: Deviations from the normal nucleoplasmic protein O-GlcNAcylation, as well as from normal protein sialylation and N-glycosylation in the secretory pathway, have been reported in Alzheimer's disease (AD). However, the interplay between the cytoplasmic protein O-GlcNAcylation and the secretory N-/O-glycosylation in AD has not been described. We present a comprehensive analysis of the N-, O-, and O-GlcNAc-glycomes in AD-affected brain regions as well as in AD patient serum. We detected marked differences in levels of glycan involved in both protein O-GlcNAcylation and N-/O-glycosylation between patients and healthy individuals and revealed brain region-specific glycosylation-related pathology in patients. These alterations are not general for other neurodegenerative conditions, such as frontotemporal dementia and corticobasal degeneration. The alterations in the AD glycome in the serum could potentially lead to novel glyco-based biomarkers for AD progression. Strikingly, negative interrelationship was found between the pathways of protein O-GlcNAcylation and N-/O-glycosylation, suggesting a novel intracellular cross-talk.

SUBMITTER: Frenkel-Pinter M 

PROVIDER: S-EPMC5600531 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Interplay between protein glycosylation pathways in Alzheimer's disease.

Frenkel-Pinter Moran M   Shmueli Merav Daniel MD   Raz Chen C   Yanku Michaela M   Zilberzwige Shai S   Gazit Ehud E   Segal Daniel D  

Science advances 20170915 9


Deviations from the normal nucleoplasmic protein O-GlcNAcylation, as well as from normal protein sialylation and N-glycosylation in the secretory pathway, have been reported in Alzheimer's disease (AD). However, the interplay between the cytoplasmic protein <i>O</i>-GlcNAcylation and the secretory N-/O-glycosylation in AD has not been described. We present a comprehensive analysis of the N-, O-, and <i>O</i>-GlcNAc-glycomes in AD-affected brain regions as well as in AD patient serum. We detected  ...[more]

Similar Datasets

| S-EPMC8146034 | biostudies-literature
| S-EPMC7215807 | biostudies-literature
| S-EPMC6137293 | biostudies-literature
| S-EPMC6700635 | biostudies-literature
| S-EPMC7425076 | biostudies-literature
| S-EPMC6928941 | biostudies-literature
2020-12-17 | GSE109349 | GEO
| PRJNA683625 | ENA